4//SEC Filing
HERON THERAPEUTICS, INC. /DE/ 4
Accession 0001209191-14-075561
$HRTXCIK 0000818033operating
Filed
Dec 14, 7:00 PM ET
Accepted
Dec 15, 8:59 PM ET
Size
8.2 KB
Accession
0001209191-14-075561
Insider Transaction Report
Form 4
Gelder Mark S. MD
SVP & Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2014-12-12+45,000→ 45,000 totalExercise: $9.05Exp: 2024-12-12→ Common Stock (45,000 underlying)
Footnotes (1)
- [F1]The stock option vests and becomes exercisable in 48 equal monthly installments beginning one month after the date of grant.
Issuer
HERON THERAPEUTICS, INC. /DE/
CIK 0000818033
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000818033
Filing Metadata
- Form type
- 4
- Filed
- Dec 14, 7:00 PM ET
- Accepted
- Dec 15, 8:59 PM ET
- Size
- 8.2 KB